论文信息 - A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2− Metastatic Breast Cancer - 字舞流文

A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2− Metastatic Breast Cancer

E. Winer | M. Berger | L. Cantley | D. Solit | D. Juric | J. Balko | M. V. Estrada | M. Sanders | H. Won | C. Arteaga | I. Mayer | L. Formisano | V. Abramson | Yisheng Li